Fosun International ( (HK:0656) ) just unveiled an announcement.
Fosun International, through its subsidiary Fosun Pharma Industrial, has increased its stake in Henlius by acquiring additional shares, bringing its total ownership to 63.43%. This acquisition, conducted through a series of transactions, highlights Fosun’s strategic focus on expanding its influence in the pharmaceutical sector. The transactions are classified as discloseable under Hong Kong’s Listing Rules, indicating their significance to the company’s financial and operational strategies.
More about Fosun International
Fosun International operates in the healthcare industry, with a focus on pharmaceuticals and medical services. The company is known for its investments in healthcare, insurance, and financial services, aiming to enhance its market presence and growth in these sectors.
YTD Price Performance: -8.73%
Average Trading Volume: 880
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.21B
Learn more about 0656 stock on TipRanks’ Stock Analysis page.